reference/3817203

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3817203

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1095
issn	1865-8652 0741-238X
issueIdentifier	12
pageRange	1089-1095
publicationName	Advances in Therapy
startingPage	1089
bibliographicCitation	Bucci FA, Waterbury LD. Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification. Adv Ther. 2011 Dec;28(12):1089–95. doi: 10.1007/s12325-011-0080-7. PMID: 22105509.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_629985bf4f51737003bdc9f0c9fc8753 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07438dcd3a25cb4589f8cd63c620a18a
date	2011-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22105509 https://doi.org/10.1007/s12325-011-0080-7
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2011 https://portal.issn.org/resource/ISSN/0741-238X https://portal.issn.org/resource/ISSN/1865-8652
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Prostaglandin E2 Inhibition of Ketorolac 0.45%, Bromfenac 0.09%, and Nepafenac 0.1% in Patients Undergoing Phacoemulsification
discusses	http://id.nlm.nih.gov/mesh/M0001335 http://id.nlm.nih.gov/mesh/M0112721 http://id.nlm.nih.gov/mesh/M0015329 http://id.nlm.nih.gov/mesh/M0002366 http://id.nlm.nih.gov/mesh/M0150453 http://id.nlm.nih.gov/mesh/M0002945 http://id.nlm.nih.gov/mesh/M0023405 http://id.nlm.nih.gov/mesh/M0370991 http://id.nlm.nih.gov/mesh/M0016543 http://id.nlm.nih.gov/mesh/M0445221
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018918Q000379 http://id.nlm.nih.gov/mesh/D001969Q000494 http://id.nlm.nih.gov/mesh/D000894Q000494 http://id.nlm.nih.gov/mesh/D044482Q000494 http://id.nlm.nih.gov/mesh/D015232Q000037 http://id.nlm.nih.gov/mesh/D010648Q000494 http://id.nlm.nih.gov/mesh/D001577Q000494 http://id.nlm.nih.gov/mesh/D020910Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D044482Q000627 http://id.nlm.nih.gov/mesh/D001577Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D009883Q000494 http://id.nlm.nih.gov/mesh/D015232Q000378 http://id.nlm.nih.gov/mesh/D010648Q000627 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D001969Q000627 http://id.nlm.nih.gov/mesh/D009883Q000627 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D020910Q000627 http://id.nlm.nih.gov/mesh/D000894Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3826 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60726 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280360 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151075 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9509 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7191

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128885449 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129010085 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879365 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129679141

Total number of triples: 68.